A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64-percent increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often prescribed to treat symptoms associated with COPD, including pain, sleep […]
Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD
Comments are closed, but trackbacks and pingbacks are open.